Stocksigma LogoStocksigma Logo

Sheel Biotech Clarifies IPO Fund Utilization for Half-Year Ended Mar'26

Sheel Biotech confirmed zero deviations in its IPO fund utilization for the half-year ended Mar'26. Of the Rs

Sheel Biotech Clarifies IPO Fund Utilization for Half-Year Ended Mar'26

Sheel Biotech Ltd 路 Others (Uncategorized) 路 02 Sept 2026, 11:50 pm

Sheel Biotech Clarifies IPO Fund Utilization for Half-Year Ended Mar'26 Sheel Biotech confirmed zero deviations in its IPO fund utilization for the half-year ended Mar'26. Of the Rs. 3,402.00 Lakhs raised, the company utilized Rs. 3,128.37 Lakhs, allocating Rs. 1,588.00 Lakhs to working capital, Rs. 665.95 Lakhs for blueberry greenhouse capex, and Rs. 472.17 Lakhs for general corporate purposes. The unutilized balance of Rs. 273.63 Lakhs remains deployed in fixed deposits. Statutory auditor certificates validate this deployment, resolving any potential market misinterpretation regarding the company's capital allocation execution.

Original exchange filing (PDF)

More announcements from Sheel Biotech Ltd

All Sheel Biotech Ltd announcements